07.06.2019 | Mia Bengtström, Senior Advisor, PIF

Welcome to the 3rd Nordic Conference on Pediatric Medicines 8-9 October 2019 in Helsinki

3rd Nordic conference will facilitate and bring forward ideas for discussion in order to accelerate medicine development for children, by providing most appropriate context for new solutions, and updating the current information related to pediatric Clinical Trials.

EU Pediatric Regulation (EC 1901/2006) came into force in 2007 with the aim to improve the health of the children in Europe by increasing the research and authorization of medicines for children and improving the information on medicines designed for children. To meet the objectives of the regulation, increasing number of pediatric clinical trials needs to be conducted. This requires more research capacity; increasing demand for investigators, centres and networks in Europe.

Since 2013, the Pharma Industry Finland together with the Finnish Investigators network for Paediatric Medicines – FinPedMed - have been facilitating academic and Pharma Industry collaboration for pediatric clinical trials in the Nordic area.

Finland’s third EU Presidency of the Council of the European Union period begins on 1 July 2019 and lasts to the end of the year. The second half of 2019 will also mark the beginning of the work of the New EU Parliament and Commission. This is important moment for all stakeholders to join the debate on a joint vision about the future parameters for pediatric medicines.

The City of Helsinki has invited the participants for a Networking event to the Old City Hall.